ClonazePAM Tablet
ClonazePAM is a compounded formulation containing ClonazePAM, prepared by Mixlab for veterinary use. Available by prescription.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Clonazepam is a benzodiazepine-class medication utilized in veterinary medicine for the management of various neurological and behavioral challenges. It is a prescription medication available for use in dogs and cats, frequently considered by veterinarians in the context of managing seizure activity or acute anxiety events. At a pharmacological level, clonazepam acts by enhancing the activity of gamma-aminobutyric acid (GABA) in the central nervous system. It binds to specific benzodiazepine receptors on the GABA-A receptor complex, which increases the inhibitory influence of GABA on neuronal excitability. This mechanism provides a method for managing the excessive electrical signaling associated with seizures and the heightened arousal seen in severe anxiety states. Clonazepam is characterized by its relatively long duration of action, which shapes its role in different management protocols. Your veterinarian will determine the clinical appropriateness of clonazepam based on your pet’s physical signs and diagnostic history.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects following the administration of clonazepam include sedation, temporary Coordination shifts (ataxia) or a noticeable increase in appetite. Some animals may exhibit paradoxical excitement or irritability rather than sedation. Long-term use in cats is approached with significant caution, as benzodiazepines have been associated with localized hepatic concerns in this species. Owners should monitor their pet for any unusual behavioral shifts or significant changes in energy levels and contact their veterinarian promptly with any concerns. This medication is typically used with extra caution or avoided in patients with known severe hepatic impairment or a history of respiratory compromise. It is also carefully evaluated in pets with a known hypersensitivity to benzodiazepines. Significant interactions can occur if clonazepam is administered concurrently with other central nervous system depressants or specific liver enzyme inhibitors. Sudden discontinuation can lead to withdrawal signs, so a structured tapering schedule is essential. Your veterinarian is the right person to provide guidance on the necessary duration of use and the most commonly considered tapering protocol to ensure the management approach remains suitable for your pet’s individual health status.
Yes. Clonazepam is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or shipped to your home.
Yes. While clonazepam is available in commercial tablet formats, Mixlab specializes in compounding the active ingredient into customized strengths and flavored dosage forms—such as flavored oral liquids—to suit the specific needs of dogs and cats. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians most commonly discuss clonazepam for managing seizure activity or acute stress-related events. Its mechanism acts to manage the excitability of neurons in the brain, providing a method for addressing excessive electrical signaling.
Sedation is a commonly observed effect of benzodiazepines like clonazepam. While some pets may appear noticeably more relaxed or tired after a dose, your veterinarian will monitor the degree of sedation to ensure it remains within a safe and appropriate clinical range for your pet's needs.
